Tag: biomarker

Alzheimer’s Drug Approval Shows Power of Protein Markers as Parkinson’s Field Seeks Same

The U.S. Food and Drug Administration (FDA) last week approved lecanemab (brand name Leqembi) developed by Eisai Co Ltd. and Biogen Inc. for people w...

Blood-Based Biomarkers in Parkinson’s

Recently, a team at Lund University published results in JAMA on a potential blood test for Alzheimer’s. It measures levels of plasma phospho-...

PPMI Study Shows Brain Changes Linked to Parkinson’s Progression

Two recent papers point to potential Parkinson’s biomarkers after analysis of data from The Michael J. Fox Foundation’s (MJFF) Parkinson’s Prog...

Making Strides Towards a Parkinson’s Biomarker

At the current time, there is no identified biomarker for Parkinson’s disease (PD). In other words, there is no objective measure — no lab or imag...

Researchers Looking to Improve Diagnosis of Parkinson’s

No objective measurement — or biomarker — currently exists to diagnose Parkinson’s disease (PD). Instead, doctors must rely on a person’s me...